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Abstract:  
Anion channels perform a diverse range of functions and have been implicated in ATP 
release, volume regulation and phosphatidylserine exposure. Platelets have been shown to 
express several anion channels however their function is incompletely understood. Due to a 
paucity of specific pharmacological blockers, we investigated the effect of extracellular 
chloride substitution on platelet activation using aggregometry and flow cytometry. In the 
absence of extracellular chloride we observed a modest reduction of the maximum 
aggregation response to thrombin or collagen-related peptide. However, the rate of 
aggregation was substantially reduced in a manner that was dependent on the extracellular 
chloride concentration and aggregation in the absence of chloride was noticeably biphasic, 
indicative of impaired secondary signalling. This was further investigated by targeting 
secondary agonists with aspirin and apyrase or by blockade of the ADP receptor P2Y12. 
Under these conditions, the rates of aggregation were comparable to those recorded in the 
absence of extracellular chloride. Finally, we assessed platelet granule release by flow 
cytometry and report a chloride-dependent element of alpha, but not dense, granule 
secretion. Taken together these data support a role for anion channels in the efficient 
induction of platelet activation, likely via enhancement of secondary signalling pathways.   
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Introduction 
In contrast to the role of cations (i.e. Ca
2+
, K
+
 and Zn
2+
) [1-3], the contribution(s) of anions to 
platelet activation remains unclear. Anion channels perform diverse functions including 
regulatory volume decrease [4], phosphatidylserine exposure [5] and ATP release [6]. Early 
patch clamp recordings demonstrated functional expression of Ca
2+
-activated Cl
-
 channels in 
platelets [7-8] and a megakaryocyte-like DAMI cell line [9]. Proteomic [10] and 
transcriptomic [11] analyses have since identified numerous anion channels that may be 
expressed by platelets. Of these, functional expression of CLIC1 (Intracellular Cl
-
 channel-1) 
[12], TMEM16F [13] and pannexin-1 [14] have been confirmed. Indicative of a haemostatic 
role for anion channels, CLIC1- and TMEM16F-deficient mice have associated platelet-
related bleeding phenotypes [12,13]. Additionally, pannexin-1 channels have been shown to 
amplify platelet activation responses to threshold agonist concentrations [14]. These ATP-
permeable channels are associated with inflammatory conditions and may contribute to 
atherosclerosis [15].  
Given the lack of specific anion channel blockers, we focus on the effect of extracellular Cl
-
 
([Cl
-
]o) substitution on platelet activation. These experiments highlight a role for anion 
channels in modulating the rate of platelet aggregation. 
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Methods 
Materials: Aspirin, apyrase and thrombin were from Sigma (Poole, UK). AR-C66096 was from 
Tocris biosciences (Bristol, UK). Cross-linked collagen-related peptide (CRP-XL) was prepared 
as described previously [16] and supplied by R. Farndale (Cambridge, UK). Unless indicated, 
all other reagents were from Sigma.  
Washed Platelet Preparation: This study was approved by the local Ethics Committee at 
Anglia Ruskin University. Human blood was collected from healthy volunteers following 
informed consent in accordance with the Declaration of Helsinki. Blood was collected into 
11mM sodium citrate and washed platelets were prepared as described previously [17]. 
Platelets were resuspended in a nominally calcium-free buffer containing (in mM): 145 NaCl, 
5 KCl, 1 MgCl2, 10 glucose, 10 HEPES, titrated to pH 7.35 with NaOH. Where indicated, [Cl
-
]o 
was substituted by equimolar gluconate. 
Aggregometry: Platelet aggregation was monitored as described previously using an 
AggRam aggregometer (Helena Biosciences, Gateshead, UK) [17]. In the experiments of Fig. 
1bc, aliquots of 151mM and 1mM [Cl
-
]o-containing platelet suspensions were mixed 5min 
prior to agonist addition. Platelets were pre-incubated with each drug(s) for 5min at 37°C.  
Granule release: Thrombin-evoked alpha and dense granule release was assessed by flow 
cytometry using fluorescently-conjugated CD62P and CD63 antibodies (BD biosciences, 
Oxford, UK), respectively. Antibody-binding was monitored for 5min using an Accuri C6 Flow 
cytometer (BD Biosciences) and the percentage positive cells was calculated within FlowJo 
(V10.2, Oregon, USA).  
Data Analysis and Statistics: Maximum aggregation (%) and the initial rate of aggregation (% 
s
-1
) were calculated in Excel, where rate was determined as the change in aggregation (%) in 
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the first 30s following shape change. Data were analysed in GraphPad Prism by two-way 
ANOVA or Student’s t-test as indicated and are representative of a minimum of four 
independent experiments. ***, **, * and ns denote P<0.001, P<0.01, P<0.05 and P>0.05, 
respectively.  
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Results 
Platelet aggregation was assessed in the presence/absence of [Cl
-
]o in response to increasing 
thrombin concentrations (Fig. 1a). Removal of [Cl
-
]o did not affect the maximum aggregation 
recorded across a 5min time course in response to 0.03, 0.3 or 1U mL
-1
 thrombin (Fig. 1aii). 
A reduction from 82.3±1.9% to 62.2±6.0% (P<0.001, Fig. 1aii) was observed at an 
intermediate concentration (0.1U mL
-1
). Cl
-
 substitution affected the kinetics of platelet 
activation as the aggregation rate decreased by 1.1±0.2, 1.1±0.2 and 1.0±0.2% s
-1
 in 
response to stimulation by 0.1, 0.3 and 1U mL
-1
 thrombin, respectively (P<0.01, Fig. 1aiii). A 
sSimilar effects wereas observed in the presence of extracellular 2mMCa
2+
 (data not 
shownFig. 1b), suggesting that this effect was not due to Ca
2+
 buffering. This 
effectobservation was not exclusive to thrombin-evoked aggregation, removal of [Cl
-
]o also 
reduced maximal CRP-XL-induced (1µg mL
-1
) aggregation by 23.5±3.9% (P<0.01, Fig. 1aii) 
and the rate decreased by 1.2±0.1% s
-1
 (P<0.001, Fig. 1aiii). The sensitivity of thrombin-
evoked (0.1U mL
-1
) aggregation to Cl
-
 was assessed by increasing [Cl
-
]o from 1 to 151mM 
(30mM increments; Fig. 1b1c). There was no change in maximum aggregation beyond 
31mM [Cl
-
]o yet rates increased across the concentration range with an( EC50= 
46.5±23.3mM).  
Differences in aggregation rate may be due to reduced secondary signalling in the absence 
of [Cl
-
]o. Platelets were pre-incubated with 100µM aspirin and 5U mL
-1
 apyrase to assess 
contributions by thromboxane A2 and extracellular nucleotides. These compounds reduced 
maximum aggregation in response to 0.1U mL
-1
 thrombin by 56.6±10.2% (P<0.001) and 
31.6±10.2% (P<0.05, Fig. 2ai, ii) in the presence of 151mM and 1mM [Cl
-
]o, respectively. The 
rate of platelet aggregation  following aspirin and apyrase treatment in the presence of 
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151mM (0.6±0.2% s
-1
) or 1mM (0.38±0.08% s
-1
) [Cl
-
]o   was comparable to that of 1mM [Cl
-
]o 
control (0.7±0.1% s
-1
; P>0.05, Fig. 2aiii). 
P2Y12-mediated signalling is a major step during integrin αIIbβ3 activation [18,19] and 
reduced ADP availability may account for the observed aggregation defect. 0.1U mL
-1
 
thrombin-evoked aggregation in the presence of a P2Y12 inhibitor (1µM AR-C66096) 
decreased by 36.7±8.2% and 51.2±7.4% in the presence of 151mM and 1mM [Cl
-
]o (P<0.01, 
Fig. 2bi), respectively. It is noteworthy that no differences between the aggregation rate of 
AR-C66096-treated platelets in 151 or 1mM [Cl
-
]o and the 1mM [Cl
-
]o control were observed 
(P>0.05, Fig. 2bii), suggesting a role for P2Y12 during Cl
-
-dependent aggregation. Finally, we 
assessed thrombin-induced granule release by flow cytometry. Peak alpha granule release 
was reduced from 72.4±2.9% to 59.9±1.6% (P<0.001, Fig. 2c), whilst dense granule release 
was unaffected by Cl
-
 substitution (P>0.05, Fig. 2c).  
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Conclusions 
Here we demonstrate that [Cl
-
]o enhances the rate of platelet aggregation in a 
concentration-dependent manner (Fig. 1). This effect was equivalent to blockade of 
secondary mediators and P2Y12 inhibition (Fig. 2). One possible explanation of these data is 
that [Cl
-
]o is required for efficient release of ATP and/or ADP from the platelet, but we failed 
to observe a change in dense granule secretion (Fig. 2c). Pannexin-1 has been shown to 
activate in response to elevation of intracellular Ca
2+
 ([Ca
2+
]i) [20], facilitating cytosolic ATP 
release [14]. It has been suggested that ADP release may occur via a similar mechanism [21]. 
Given that release of alpha granule cargo (e.g. fibrinogen, thrombin and Zn
2+
) is required for 
aggregation and is enhanced by P2Y12 signalling [22-24], it is possible that [Cl
-
]o enhances 
platelet activation by mediating efficient alpha granule secretion.  
Reduction of [Cl
-
]o has been shown to substantially reduce thrombin-plus-CRP-XL-mediated 
elevation of [Ca
2+
]i in a similar manner to that of Cl
-
 channel blockers [25]. It has been 
suggested that Cl
-
 currents hyperpolarise the cell, increasing driving force for Ca
2+
 influx [9]. 
However, the platelet Cl
-
 equilibrium is ≈35mV in the platelet [7], meaning activation of a Cl
-
 
conductance would depolarise rather than hyperpolarise platelets. Reduced Ca
2+
 influx may 
be due to reduced secondary signalling, rather than altered membrane potential.  
We have focused on the contribution of [Cl
-
]o by way of ionic substitution experiments 
because of the paucity of specific pharmacological tools to study anion channels. This may 
also explain why anion channels have previously received much less attention than cation 
channels. It is worth noting that anion channels have been associated with cystic fibrosis, 
bleeding phenotypes and inflammatory conditions [12,13,15,26,27] and may represent 
valuable therapeutic targets, as demonstrated by clinical use of CFTR modulators [28]. 
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Further work will be required to investigate the contribution(s) by the cohort of platelet 
anion channels during platelet activation. 
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Figure 1: Extracellular chloride is required for efficient platelet activation. (a) Washed platelets 
were stimulated by increasing concentrations of thrombin or 1µg mL-1 CRP-XL in the presence of 151mM 
(black) or 1mM (grey) [Cl-]o. Representative aggregation traces are shown for each condition (ai). Maximum 
aggregation (aii) and the initial rate of aggregation (aiii) were calculated for each condition. (b) Removal of 
[Cl-]o continued to reduce the initial rate of thrombin-evoked aggregation in the presence of 2mM CaCl2. (c) 
The sensitivity of thrombin-evoked (0.1U mL-1) aggregation to Cl- was assessed by increasing [Cl-]o from 1 
to 151mM in 30mM increments. Representative traces (ci), maximum (cii) and initial rate of thrombin-
induced (0.1U mL-1) aggregation (ciii) for each [Cl-]o are shown. The rate of aggregation increased across 
the concentration range with an EC50= 46.5±23.3mM. Data are representative of a minimum of four 
independent experiments. Thrombin and CRP-XL data sets were analysed by two-way ANOVA and Student’s 
t test, respectively.  
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Figure 2: Role for secondary signalling during Cl--dependent platelet aggregation. (a) Washed 
platelets were pre-incubated with 100µM aspirin (cyclooxygenase inhibitor) and 5U mL-1 apyrase 
(ectonucleotidase) prior to performing aggregometry in the presence of 151mM (black) or 1mM (grey) [Cl-]o. 
Representative traces (ai), maximum (aii) and initial rate (aiii) of thrombin-induced (0.1U mL-1) aggregation 
are shown in the presence of vehicle control (0.1% ethanol) or aspirin plus apyrase. (b) Summary data for 
maximum (bi) and initial rate of thrombin-evoked (0.1U mL-1) platelet aggregation (bii) in the presence of 
vehicle control (H2O) or 1µM Ar-C66096 (P2Y12 inhibitor). (c) Alpha (i) and dense (ii) granule release 
before (Unstim.) and after 0.1U mL-1 thrombin stimulation was assessed by flow cytometry using 
fluorescently-labelled CD62P and CD63 antibodies, respectively. Data are representative of a minimum of 
four independent experiments and data were analysed by two-way ANOVA.  
 
175x294mm (300 x 300 DPI)  
Page 17 of 16
URL: http://mc.manuscriptcentral.com/cpla E-mail: P.Harrison.1@bham.ac.uk
Platelets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 
 
Page 18 of 16
URL: http://mc.manuscriptcentral.com/cpla E-mail: P.Harrison.1@bham.ac.uk
Platelets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
